Literature DB >> 35146728

Comparison of manual and automated digital image analysis systems for quantification of cellular protein expression.

T Jagomast1, C Idel2, L Klapper3, P Kuppler3, L Proppe4, S Beume4, M Falougy5, D Steller5, S G Hakim5, A Offermann3, M C Roesch6, K L Bruchhage7, S Perner3,8, J Ribbat-Idel3.   

Abstract

OBJECTIVE: Quantifying protein expression in immunohistochemically stained histological slides is an important tool for oncologic research. The use of computer-aided evaluation of IHC-stained slides significantly contributes to objectify measurements. Manual digital image analysis (mDIA) requires a user-dependent annotation of the region of interest (ROI). Others have built-in machine learning algorithms with automated digital image analysis (aDIA) and can detect the ROIs automatically. We aimed to investigate the agreement between the results obtained by aDIA and those derived from mDIA systems.
METHODS: We quantified chromogenic intensity (CI) and calculated the positive index (PI) in cohorts of tissue microarrays (TMA) using mDIA and aDIA. To consider the different distributions of staining within cellular sub-compartments and different tumor architecture our study encompassed nuclear and cytoplasmatic stainings in adenocarcinomas and squamous cell carcinomas.
RESULTS: Within all cohorts, we were able to show a high correlation between mDIA and aDIA for the CI (p<0.001) along with high agreement for the PI. Moreover, we were able to show that the cell detections of the programs were comparable as well and both proved to be reliable when compared to manual counting.
CONCLUSION: mDIA and aDIA show a high correlation in acquired IHC data. Both proved to be suitable to stratify patients for evaluation with clinical data. As both produce the same level of information, aDIA might be preferable as it is time-saving, can easily be reproduced, and enables regular and efficient output in large studies in a reasonable time period.

Entities:  

Mesh:

Year:  2022        PMID: 35146728     DOI: 10.14670/HH-18-434

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.130


  44 in total

Review 1.  Measuring agreement in method comparison studies.

Authors:  J M Bland; D G Altman
Journal:  Stat Methods Med Res       Date:  1999-06       Impact factor: 3.021

Review 2.  Applying the right statistics: analyses of measurement studies.

Authors:  J M Bland; D G Altman
Journal:  Ultrasound Obstet Gynecol       Date:  2003-07       Impact factor: 7.299

Review 3.  The Gold Standard Paradox in Digital Image Analysis: Manual Versus Automated Scoring as Ground Truth.

Authors:  Famke Aeffner; Kristin Wilson; Nathan T Martin; Joshua C Black; Cris L Luengo Hendriks; Brad Bolon; Daniel G Rudmann; Roberto Gianani; Sally R Koegler; Joseph Krueger; G Dave Young
Journal:  Arch Pathol Lab Med       Date:  2017-05-30       Impact factor: 5.534

4.  Quantification of protein expression in cells and cellular subcompartments on immunohistochemical sections using a computer supported image analysis system.

Authors:  Martin Braun; Robert Kirsten; Niels J Rupp; Holger Moch; Falko Fend; Nicolas Wernert; Glen Kristiansen; Sven Perner
Journal:  Histol Histopathol       Date:  2013-01-30       Impact factor: 2.303

5.  Integrated tumor identification and automated scoring minimizes pathologist involvement and provides new insights to key biomarkers in breast cancer.

Authors:  Peter Bankhead; José A Fernández; Darragh G McArt; David P Boyle; Gerald Li; Maurice B Loughrey; Gareth W Irwin; D Paul Harkin; Jacqueline A James; Stephen McQuaid; Manuel Salto-Tellez; Peter W Hamilton
Journal:  Lab Invest       Date:  2017-12-18       Impact factor: 5.662

Review 6.  Biomarker studies: a call for a comprehensive biomarker study registry.

Authors:  Fabrice Andre; Lisa M McShane; Stefan Michiels; David F Ransohoff; Douglas G Altman; Jorge S Reis-Filho; Daniel F Hayes; Lajos Pusztai
Journal:  Nat Rev Clin Oncol       Date:  2011-03       Impact factor: 66.675

7.  Machine learning based brain tumour segmentation on limited data using local texture and abnormality.

Authors:  Stijn Bonte; Ingeborg Goethals; Roel Van Holen
Journal:  Comput Biol Med       Date:  2018-05-07       Impact factor: 4.589

8.  ERG protein expression and genomic rearrangement status in primary and metastatic prostate cancer--a comparative study of two monoclonal antibodies.

Authors:  M Braun; D Goltz; D Adler; W Vogel; D Böhm; V Scheble; K Sotlar; F Fend; S-H Tan; A Dobi; G Kristiansen; N Wernert; S Perner
Journal:  Prostate Cancer Prostatic Dis       Date:  2012-01-10       Impact factor: 5.554

9.  QuPath: Open source software for digital pathology image analysis.

Authors:  Peter Bankhead; Maurice B Loughrey; José A Fernández; Yvonne Dombrowski; Darragh G McArt; Philip D Dunne; Stephen McQuaid; Ronan T Gray; Liam J Murray; Helen G Coleman; Jacqueline A James; Manuel Salto-Tellez; Peter W Hamilton
Journal:  Sci Rep       Date:  2017-12-04       Impact factor: 4.379

10.  An open source automated tumor infiltrating lymphocyte algorithm for prognosis in melanoma.

Authors:  Balazs Acs; Fahad Shabbir Ahmed; Swati Gupta; Pok Fai Wong; Robyn D Gartrell; Jaya Sarin Pradhan; Emanuelle M Rizk; Bonnie Gould Rothberg; Yvonne M Saenger; David L Rimm
Journal:  Nat Commun       Date:  2019-11-29       Impact factor: 14.919

View more
  2 in total

1.  ICOSeg: Real-Time ICOS Protein Expression Segmentation from Immunohistochemistry Slides Using a Lightweight Conv-Transformer Network.

Authors:  Vivek Kumar Singh; Md Mostafa Kamal Sarker; Yasmine Makhlouf; Stephanie G Craig; Matthew P Humphries; Maurice B Loughrey; Jacqueline A James; Manuel Salto-Tellez; Paul O'Reilly; Perry Maxwell
Journal:  Cancers (Basel)       Date:  2022-08-13       Impact factor: 6.575

2.  CDK7 is a prognostic biomarker for non-small cell lung cancer.

Authors:  Christiane Kuempers; Tobias Jagomast; Carsten Heidel; Finn-Ole Paulsen; Sabine Bohnet; Stefanie Schierholz; Eva Dreyer; Jutta Kirfel; Sven Perner
Journal:  Front Oncol       Date:  2022-09-23       Impact factor: 5.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.